Daily Manufacturing Eye-Vite Plus™ (Vitamin's A, C, E, Zinc, Gamma Aminobutyric Acid (GABA), Lutein, Zeaxanthin & Bilberry)
- Daily Eye-Vite2 combines the most important nutrients at the optimal dosages for maintaining visual health.
- One tablet provides: Vitamin A 1250 IU (375 mcg RAE, Palmitate), Vitamin C 200 mg, Vitamin E 90 mg (200 IU) (d-alpha tocopherol), Zinc 12.5 mg (zinc citrate), Gamma Aminobutyric Acid 250 mg (GABA), Lutein 10 mg, Lycopene 2.5 mg, Zeaxanthin 2.5 mg, Bilberry Ext. 30 mg.
- Gluten Free, Soy Free, Vegan. 60 Tablets per bottle.
- Made in the USA by Daily Manufacturing a family owned IS0-9001:2015 registered FDA inspected facility.
Daily Eye-Vite Plus combines the most important nutrients at the optimal dosages for maintaining visual health. One tablet provides: Vitamin A 1250 IU (375 mcg RAE, Palmitate), Vitamin C 200 mg, Vitamin E 90 mg (200 IU) (d-alpha tocopherol), Zinc 12.5 mg (zinc citrate), Gamma Aminobutyric Acid 250 mg (GABA), Lutein 10 mg, Lycopene 2.5 mg, Zeaxanthin 2.5 mg, Bilberry Ext. 30 mg. (cellulose, stearic acid, silicon dioxide, Gluten Free, Soy Free, Vegan) 60 Tablets per bottle.
Important information
Ingredients
Vitamin's A, C, E, Zinc, Gamma Aminobutyric Acid (GABA), Lutein, Zeaxanthin & Bilberry
Legal Disclaimer
Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.
Package Dimensions
3.4 x 1.8 x 1.1 inches; 0.81 ounces
Дэлгэрэнгүй тодорхойлолт
| Primary Supplement Type | C, E, Lutein, Zinc, Vitamin's A, Gamma Aminobutyric Acid (gaba), Bilberry |
| Diet Type | Gluten Free, Vegan |
| Special Ingredients | E, C, Zinc, Lutein, Vitamin's A, Gamma Aminobutyric Acid, Zeaxanthin |
| Brand | Daily Manufacturing |
| Expiry Date | Aug 2027 |
| Unit Count | 1.00 Count |
| Item Form | Capsule |
| Item Weight | 0.02 Kilograms |
| Age Range (description) | Adult |
| Number Of Items | 1 |
| Format | Bottle |
| Product Type | Nutritional Supplement |
| Tags | |
|---|---|
| Tags | |